Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01741311 · ClinicalTrials.gov registry record · NA
Secondary HIV Prevention and Adherence Among HIV-infected Drug Users
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT01741311: Completed NA study, sponsored by University of Connecticut.
NCT01741311 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01741311, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
This study will test whether 3H+ (Holistic Health for HIV) is comparable to the original HHRP+ (Holistic Health Recovery Program) in reducing HIV risk behaviors and improving ART (Antiretroviral Therapy) adherence in a randomized controlled comparative effectiveness trial among 256 HIV+ persons in drug treatment who report unsafe injection drug use practices or sexual risk behavior.
Primary Outcome
Anti-retroviral therapy (ART) adherence was assessed by self-report using the visual analogue scale (VAS). The VAS measures adherence continuously from 0 to 100%, with higher scores indicating better adherence to the medication. A greater number of participants with optimal ART adherence is better. Optimal ART adherence is defined as a score \>95% on the visual analog scale (VAS).
Interventions
- BEHAVIORAL 3H+ (Holistic Health for HIV)
- BEHAVIORAL HHRP+ (Holistic Health Recovery Program)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2012-09 |
| Est. Completion | 2018-06 |
| Phase | NA |
What the finished NCT01741311 record still lists
NCT01741311 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which 3H+ (Holistic Health for HIV) is the first listed.
NCT01741311 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01741311 about?
NCT01741311 is a clinical study titled "Secondary HIV Prevention and Adherence Among HIV-infected Drug Users". This study will test whether 3H+ (Holistic Health for HIV) is comparable to the original HHRP+ (Holistic Health Recovery Program) in reducing HIV risk behaviors and improving ART (Antiretroviral Therapy) adherence in a randomized controlled comparative effectiveness trial among 256 HIV+ persons in d...
What is the current status of trial NCT01741311?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2012-09. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01741311?
The interventions under investigation include: 3H+ (Holistic Health for HIV) (BEHAVIORAL), HHRP+ (Holistic Health Recovery Program) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01741311?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01741311's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia